Literature DB >> 8001772

A haemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis.

F M Billson1, J L Hodgson, J R Egerton, A W Lepper, W P Michalski, C L Schwartzkoff, P R Lehrbach, J M Tennent.   

Abstract

Protection conferred by a cell-free preparation from a haemolytic Moraxella bovis isolate, UQV 148NF, was compared to an equivalent fraction from a non-haemolytic M. bovis isolate, Gordon 26L3, and to a recombinant DNA-derived pili vaccine. Three groups of ten calves were vaccinated twice with one of the three preparations and, together with ten non-vaccinated calves, challenged with virulent M. bovis isolate Dal 2d. Compared to the control group, significant protection was observed in the group receiving the pili vaccine and the group receiving the preparation from haemolytic isolate, UQV 148NF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001772     DOI: 10.1111/j.1574-6968.1994.tb07263.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  4 in total

1.  Molecular characterization of a secreted enzyme with phospholipase B activity from Moraxella bovis.

Authors:  J L Farn; R A Strugnell; P A Hoyne; W P Michalski; J M Tennent
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

2.  Ocular immune responses in steers following intranasal vaccination with recombinant Moraxella bovis cytotoxin adjuvanted with polyacrylic acid.

Authors:  John A Angelos; Judy M Edman; Munashe Chigerwe
Journal:  Clin Vaccine Immunol       Date:  2013-12-11

3.  Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody.

Authors:  F M Billson; C Harbour; W P Michalski; J M Tennent; J R Egerton; J L Hodgson
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Effects of Moraxella (Branhamella) ovis culture filtrates on bovine erythrocytes, peripheral mononuclear cells, and corneal epithelial cells.

Authors:  Henry E Cerny; Douglas G Rogers; Jeffrey T Gray; David R Smith; Susanne Hinkley
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.